Mutations in GNA11 in Uveal Melanoma

A specific amino acid in the Gα 11 subunit of heterotrimeric G proteins was mutated in 32% of primary uveal melanomas and in 57% of uveal melanoma metastases analyzed in this study. This variant was found to activate the mitogen-activated protein kinase pathway. Uveal melanoma is a neoplasm that ari...

Full description

Saved in:
Bibliographic Details
Published inThe New England journal of medicine Vol. 363; no. 23; pp. 2191 - 2199
Main Authors Van Raamsdonk, Catherine D, Griewank, Klaus G, Crosby, Michelle B, Garrido, Maria C, Vemula, Swapna, Wiesner, Thomas, Obenauf, Anna C, Wackernagel, Werner, Green, Gary, Bouvier, Nancy, Sozen, M. Mert, Baimukanova, Gail, Roy, Ritu, Heguy, Adriana, Dolgalev, Igor, Khanin, Raya, Busam, Klaus, Speicher, Michael R, O'Brien, Joan, Bastian, Boris C
Format Journal Article
LanguageEnglish
Published Waltham, MA Massachusetts Medical Society 02.12.2010
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A specific amino acid in the Gα 11 subunit of heterotrimeric G proteins was mutated in 32% of primary uveal melanomas and in 57% of uveal melanoma metastases analyzed in this study. This variant was found to activate the mitogen-activated protein kinase pathway. Uveal melanoma is a neoplasm that arises from melanocytes of the choroid plexus, ciliary body, and iris of the eye. 1 Unlike cutaneous melanoma, uveal melanoma lacks mutations in BRAF, NRAS, or KIT 2 – 5 and has characteristic cytogenetic alterations 6 and a strong tendency to metastasize to the liver. 1 , 7 The nevus of Ota, a subtle intradermal proliferation of melanocytes resulting in bluish-gray hyperpigmentation in the sclera and periorbital dermis, is a risk factor for uveal melanoma. 8 In mice, germline mutations that increase the activity of the closely related GTPases, Gα q (V179M) and Gα 11 (I63V), cause dermal hyperpigmentation. 9 The microscopical . . .
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Drs. Van Raamsdonk, Griewank, Crosby, and Garrido and Ms. Vemula contributed equally to this article.
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJMoa1000584